Geulah Livshits
Stock Analyst at Chardan Capital
(2.03)
# 1,000
Out of 4,479 analysts
128
Total ratings
38.46%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $62 | $19.78 | +213.45% | 10 | Jun 28, 2024 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $7 | $2.16 | +224.07% | 9 | Jun 18, 2024 | |
| PRME Prime Medicine | Initiates: Buy | $17 | $5.28 | +221.97% | 1 | Apr 22, 2024 | |
| ACHL Achilles Therapeutics | Maintains: Buy | $11 → $6 | $0.83 | +619.68% | 5 | Apr 5, 2024 | |
| MGX Metagenomi | Maintains: Buy | $21 | $4.23 | +396.45% | 2 | Mar 28, 2024 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $20 | $2.98 | +572.27% | 7 | Mar 21, 2024 | |
| IMRX Immuneering | Maintains: Buy | $21 → $16 | $1.09 | +1,367.89% | 6 | Mar 15, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $110 → $112 | $53.12 | +110.86% | 9 | Feb 22, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $29 → $34 | $7.73 | +339.84% | 10 | Feb 20, 2024 | |
| LXEO Lexeo Therapeutics | Initiates: Buy | $23 | $14.02 | +64.05% | 1 | Nov 28, 2023 | |
| SNTI Senti Biosciences | Reiterates: Buy | $6 | $0.39 | +1,438.46% | 5 | Aug 15, 2023 | |
| FDMT 4D Molecular Therapeutics | Reiterates: Buy | $31 | $20.58 | +50.63% | 3 | Aug 11, 2023 | |
| MGTX MeiraGTx Holdings | Reiterates: Buy | $41 | $3.94 | +940.61% | 4 | Aug 11, 2023 | |
| IPSC Century Therapeutics | Maintains: Buy | $19 → $17 | $2.21 | +669.23% | 3 | Aug 10, 2023 | |
| KRYS Krystal Biotech | Maintains: Buy | $148 → $153 | $177.61 | -13.86% | 5 | Aug 8, 2023 | |
| PASG Passage Bio | Maintains: Buy | $11 → $9 | $1.00 | +800.36% | 2 | Aug 8, 2023 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $107 | $22.15 | +383.07% | 10 | Aug 7, 2023 | |
| EDIT Editas Medicine | Maintains: Buy | $22 → $19 | $4.54 | +318.50% | 7 | Aug 3, 2023 | |
| IMTX Immatics | Maintains: Buy | $28 → $25 | $12.02 | +107.99% | 2 | Mar 23, 2023 | |
| CABA Cabaletta Bio | Reiterates: Buy | $12 | $7.39 | +62.38% | 4 | Mar 22, 2023 | |
| MRNA Moderna | Maintains: Neutral | $191 → $208 | $117.07 | +77.67% | 7 | Jan 18, 2023 | |
| PDSB PDS Biotechnology | Maintains: Buy | $15 → $16 | $2.95 | +442.37% | 3 | Nov 15, 2022 | |
| LOGC ContextLogic | Maintains: Buy | $4 → $2.5 | $5.67 | -55.91% | 4 | Aug 22, 2022 | |
| SLDB Solid Biosciences | Maintains: Buy | $105 → $90 | $5.96 | +1,410.07% | 3 | Aug 12, 2022 | |
| RGNX REGENXBIO | Maintains: Buy | n/a | $10.75 | - | 1 | Nov 3, 2021 | |
| VYGR Voyager Therapeutics | Maintains: Neutral | n/a | $7.59 | - | 1 | Nov 3, 2021 | |
| VINC Vincerx Pharma | Maintains: Buy | n/a | $0.74 | - | 2 | Aug 13, 2021 | |
| ADVM Adverum Biotechnologies | Maintains: Neutral | $50 → $30 | $6.84 | +338.60% | 1 | Jul 23, 2021 | |
| IMNM Immunome | Initiates: Buy | n/a | $11.70 | - | 1 | Oct 27, 2020 |
Rocket Pharmaceuticals
Jun 28, 2024
Maintains: Buy
Price Target: $62
Current: $19.78
Upside: +213.45%
Taysha Gene Therapies
Jun 18, 2024
Maintains: Buy
Price Target: $7
Current: $2.16
Upside: +224.07%
Prime Medicine
Apr 22, 2024
Initiates: Buy
Price Target: $17
Current: $5.28
Upside: +221.97%
Achilles Therapeutics
Apr 5, 2024
Maintains: Buy
Price Target: $11 → $6
Current: $0.83
Upside: +619.68%
Metagenomi
Mar 28, 2024
Maintains: Buy
Price Target: $21
Current: $4.23
Upside: +396.45%
Tenaya Therapeutics
Mar 21, 2024
Reiterates: Buy
Price Target: $20
Current: $2.98
Upside: +572.27%
Immuneering
Mar 15, 2024
Maintains: Buy
Price Target: $21 → $16
Current: $1.09
Upside: +1,367.89%
CRISPR Therapeutics AG
Feb 22, 2024
Maintains: Buy
Price Target: $110 → $112
Current: $53.12
Upside: +110.86%
Iovance Biotherapeutics
Feb 20, 2024
Maintains: Buy
Price Target: $29 → $34
Current: $7.73
Upside: +339.84%
Lexeo Therapeutics
Nov 28, 2023
Initiates: Buy
Price Target: $23
Current: $14.02
Upside: +64.05%
Senti Biosciences
Aug 15, 2023
Reiterates: Buy
Price Target: $6
Current: $0.39
Upside: +1,438.46%
4D Molecular Therapeutics
Aug 11, 2023
Reiterates: Buy
Price Target: $31
Current: $20.58
Upside: +50.63%
MeiraGTx Holdings
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $3.94
Upside: +940.61%
Century Therapeutics
Aug 10, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $2.21
Upside: +669.23%
Krystal Biotech
Aug 8, 2023
Maintains: Buy
Price Target: $148 → $153
Current: $177.61
Upside: -13.86%
Passage Bio
Aug 8, 2023
Maintains: Buy
Price Target: $11 → $9
Current: $1.00
Upside: +800.36%
Intellia Therapeutics
Aug 7, 2023
Reiterates: Buy
Price Target: $107
Current: $22.15
Upside: +383.07%
Editas Medicine
Aug 3, 2023
Maintains: Buy
Price Target: $22 → $19
Current: $4.54
Upside: +318.50%
Immatics
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $12.02
Upside: +107.99%
Cabaletta Bio
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $7.39
Upside: +62.38%
Moderna
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $117.07
Upside: +77.67%
PDS Biotechnology
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $2.95
Upside: +442.37%
ContextLogic
Aug 22, 2022
Maintains: Buy
Price Target: $4 → $2.5
Current: $5.67
Upside: -55.91%
Solid Biosciences
Aug 12, 2022
Maintains: Buy
Price Target: $105 → $90
Current: $5.96
Upside: +1,410.07%
REGENXBIO
Nov 3, 2021
Maintains: Buy
Price Target: n/a
Current: $10.75
Upside: -
Voyager Therapeutics
Nov 3, 2021
Maintains: Neutral
Price Target: n/a
Current: $7.59
Upside: -
Vincerx Pharma
Aug 13, 2021
Maintains: Buy
Price Target: n/a
Current: $0.74
Upside: -
Adverum Biotechnologies
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $6.84
Upside: +338.60%
Immunome
Oct 27, 2020
Initiates: Buy
Price Target: n/a
Current: $11.70
Upside: -